Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MenABCWY Vaccine in Healthy Adolescents
NCT04440176Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jun 2020
- Primary completion
- Jan 2024
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Meningococcal ABCYW vaccine in meningococcal disease, sponsored by Pfizer. Started Jun 2020; status: completed.
02
Drugs
Meningococcal ABCYW vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on NCT04440176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04440176.